Mira Pharmaceuticals MIRA
NASDAQ MIRA
$0.63 -0.05 (-7.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Mira Pharmaceuticals (MIRA) Shares Outstanding (Entity) (2022 - 2025)

Updated

Mira Pharmaceuticals (MIRA) reported Shares Outstanding (Entity) of 23.69 million for the quarter ended Dec 31, 2025, up 43.1% from 16.56 million a year earlier and up 22.9% from the prior quarter.

Analysis

Mira Pharmaceuticals (MIRA) Shares Outstanding (Entity) (2022 - 2025) Analysis & Trends

Dating back to the quarter ended Sep 30, 2022, Mira Pharmaceuticals' Shares Outstanding (Entity) record includes 14 quarters.

  • Shares Outstanding (Entity) has a three-year compound annual growth rate of 10.5% (years ended Dec 2022 to Dec 2025).
  • By year, Shares Outstanding (Entity) came in at 16.56 million in the year ended Dec 31, 2024 (-10.8%), 18.57 million in the year ended Dec 31, 2023 (+5.7%) and 17.57 million in the year ended Dec 31, 2022.
  • The figure for the quarter ended Dec 31, 2025 ranks as the highest quarterly Shares Outstanding (Entity) in data going back to the quarter ended Sep 30, 2022.
  • Year over year, Shares Outstanding (Entity) has now increased in each of the last three quarters, with growth averaging 10.7% over the last eight quarters.
  • The high point for year-over-year Shares Outstanding (Entity) in five years was the quarter ended Dec 31, 2025 (growth of 43.1%); the low point was the quarter ended Mar 31, 2025 (a decline of 14.7%).
  • Per Business Quant data, the three quarters before the quarter ended Dec 31, 2025 came in at 19.27 million (quarter ended Sep 30, 2025), 17.39 million (quarter ended Jun 30, 2025) and 16.81 million (quarter ended Mar 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 941.36 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.41 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 1.77 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 540.60 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 1.24 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 5.70 Bn
10 Mira Pharmaceuticals 14.93 Mn -5.58 Mn - 23.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 23.69 Mn
Sep 30, 2025 19.27 Mn
Jun 30, 2025 17.39 Mn
Mar 31, 2025 16.81 Mn
Dec 31, 2024 16.56 Mn
Sep 30, 2024 16.27 Mn
Jun 30, 2024 14.78 Mn
Mar 31, 2024 19.71 Mn
Dec 31, 2023 18.57 Mn
Sep 30, 2023 14.78 Mn
Jun 30, 2023 13.31 Mn
Mar 31, 2023 17.75 Mn
Dec 31, 2022 17.57 Mn
Sep 30, 2022 13.26 Mn
Jun 30, 2022 13.08 Mn
API Access

Mira Pharmaceuticals Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=MIRA&period=max&api_key=YOUR_API_KEY